Our Company

Patient-Inspired Solutions

Alkermes seeks to develop innovative medicines that help address the unmet needs and challenges of people living with debilitating diseases. As a fully-integrated, global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.

Through our proven scientific, development and manufacturing capabilities, Alkermes is uniquely positioned to be an engine of innovative treatments for major clinical conditions specifically focused on neuroscience and oncology.

Our approach to development is reflected in our:

  • Proven scientific expertise, as reflected in our diversified commercial product portfolio;
  • Pipeline of novel product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer;
  • Proprietary science and technology that have the potential to lead to the discovery of new, patentable medicines; and
  • Commitment to developing new treatment options for major diseases with patient needs in mind.

All this, combined with our highly-skilled employees, our culture of respect for all voices, and our global presence, help position us as a leading innovator in the global biopharmaceutical industry.

Other Resources

Email Alerts

Stay in Touch with Alkermes